v3.26.1
INVESTMENT IN BC THERAPEUTICS INC. (Tables)
9 Months Ended
Apr. 30, 2026
Investments, All Other Investments [Abstract]  
SCHEDULE OF CHANGES IN INVESTMENT

Changes in the Company’s equity investment in BC Therapeutics is summarized as follows:

 

Balance – August 1, 2024  $418,490 
Funding (including the value of the BC Therapeutics Options)   330,000 
Share of losses   (224,212)
Balance – July 31, 2025   524,278 
Exercise of BC Therapeutic Options during the period (funding)    260,000 
Fair value of BC Therapeutics Options on February 1, 2026   

193,829

 
Change in fair value during the period     (55,999 ) 
Share of losses   (171,126)
Balance – April 30, 2026  $750,982 
SCHEDULE OF ASSETS AND LIABILITIES OF BC THERAPEUTICS

The following amounts represent the Company’s 69% share of the assets of BC Therapeutics (July 31, 2025 – 63.1%):

 

  

As of

April 30, 2026

 
Current assets: Cash  $2,117 
Net assets  $2,117